Sun Pharma To Acquire Ranbaxy In $4 Billion Deal
Advertisement
MUMBAI: Sun Pharma and Ranbaxy Laboratories announced that they have entered into definitive agreements pursuant to which the former will acquire 100% of Ranbaxy in an all-stock transaction. The deal being termed as a "landmark transaction", has been estimated at $4 billion.
Under terms of the agreed deal, Ranbaxy shareholders will get 0.8 of aSun Pharmaceutical share for each Ranbaxy share they own. The exchange ratio represents an implied value of Rs 457 for each Ranbaxy share, a premium of 18% to Ranbaxy’s 30-day volume-weighted average share price and a premium of 24.3% to Ranbaxy's 60-day volume-weighted average share price, in each case, as of the close of business on April 4, 2014, said the statement.
The combination of Sun Pharma and Ranbaxy will be the fifth-largest specialty generics company in the world and the largest pharmaceutical company in India.
The merged entity would create a newmarket leader in the immensely fragmented Rs 75,000 crore domestic pharma market, with the company commanding close 9.3% market share , according to AIOCD AWACS.
Advertisement
Advertisement
Under terms of the agreed deal, Ranbaxy shareholders will get 0.8 of a
The combination of Sun Pharma and Ranbaxy will be the fifth-largest specialty generics company in the world and the largest pharmaceutical company in India.
The merged entity would create a new
Advertisement
- Voter turnout numbers affecting sentiments, but Indian markets to soon get an upsurge: Expert
- Markets decline in early trade amid weak global trends, unabated foreign fund outflows
- Rupee opens on flat note against US dollar in early trade; Underperformance partly due to election worries
- International Business Expansion
- Average housing prices up 10% in Jan-Mar across the top eight cities
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market